Phosphorylation of a critical residue in the activation loop of many protein kinases is essential for enzymatic activity. The trimeric complex CDK7/cyclin H/Mat1 phosphorylates the cell cycle regulated cyclin-dependent kinase, CDK2 at Thr-160 in the activation segment in vitro. Whether CDK7/cyclin H is the in vivo CDK2 activating kinase (CAK), or the sole CAK for CDK2 remains elusive. Here we show that monomeric human CDK2 purified from bacteria is phosphorylated at Thr-160. CDK2 expressed and purified from bacteria exhibited kinase activity against histone H1, which was stimulated by cyclin E or A expressed and purified from bacteria. The kinase activity was dependent on both the catalytic activity of CDK2 and Thr-160 phosphorylation since it was abolished when CDK2 was mutated at Lys33 in the ATP binding site (K33R) or Thr160 (T160A) or when treated with lambda phosphatase. Mass spectrometry based phosphopeptide mapping confirmed the phosphorylation of bacterial CDK2 on Thr160. Consistent with a role of CDK2 in auto-activation, inhibition of CDK2 in human cells either by pharmacological inhibition of CDK2 or by the coexpression of the CDK2 inhibitors p21 or p27, inhibited CDK2 Thr-160 phosphorylation. Our results demonstrate that CDK2 is capable of autophosphorylation at Thr160.
SciCrunch is a data sharing and display platform. Anyone can create a custom portal where they can select searchable subsets of hundreds of data sources, brand their web pages and create their community. SciCrunch will push data updates automatically to all portals on a weekly basis. User communities can also add their own data to scicrunch, however this is not currently a free service.